Cardio-oncology/onco-cardiology

Area of Science:

• Cardio-oncology
• Cardiotoxicity
• Cardiovascular Medicine

Background:

• Cancer therapies, including chemotherapy and radiation, frequently cause cardiotoxicity.
• Cardiotoxicity manifests in various forms, such as cardiac dysfunction, ischemia, arrhythmias, and pericarditis.

Purpose of the Study:

• To highlight the critical role of cardio-oncology in managing cancer patients.
• To outline the diverse cardiotoxic effects of cancer treatments.
• To emphasize the need for cardiovascular evaluation and monitoring.

Main Methods:

• Review of cardiotoxic effects associated with antineoplastic agents and radiation therapy.
• Discussion of cardiovascular evaluation protocols for cancer patients.
• Consideration of pharmacologic interventions to mitigate cardiotoxicity.

Main Results:

• All antineoplastic agents carry a risk of cardiotoxicity.
• Radiation therapy can lead to long-term cardiac damage.
• Proactive cardiovascular assessment and monitoring are essential for cancer patients.

Conclusions:

• Cardio-oncology is crucial for optimizing cancer patient care.
• Early cardiovascular evaluation and serial monitoring can detect and manage treatment-related cardiac issues.
• Collaborative care between cardiologists and oncologists is vital.